About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6717173
Allelic
Composition
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Genetic
Background
involves: C57BL/6 * C57BL/6N * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Speer6-ps1Tg(Alb-cre)21Mgn mutation (6 available); any Speer6-ps1 mutation (4 available)
Zc3h12atm1c(EUCOMM)Hmgu mutation (1 available); any Zc3h12a mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
liver/biliary system
• mice show the eventual disruption of the bile duct epithelium
• extensive bile duct hyperplasia at 6 weeks of age
• 6 to 52-week-old mice show extensive parenchymal inflammation
• mice of all ages show increased leukocyte infiltration into the liver parenchyma; the predominant population of leukocytes is T lymphocytes in 6-week-old-mice, while 24-week-old mice show an additional accumulation of B lymphocytes, macrophages and neutrophils
• 6 to 52-week-old mice show extensive parenchymal inflammation and parenchymal fibrosis
• 6 to 52-week-old mice show parenchymal fibrosis and fibrosis in portal areas
• active and progressive proliferation of intrahepatic bile ducts is seen in 6 to 52-week-old mice, with intrahepatic and periportal cholangiocyte proliferation
• symptoms of primary biliary cholangitis are already seen at P10; intrahepatic bile duct pathology is extensive at 6 weeks, less severe in the liver parenchyma at 24 weeks, and modestly reintensified by 52 weeks
• males and females show the same features of primary biliary cholangitis
• mice show bile duct lumen obstruction due to proliferation of bile ducts, bile duct epithelium disruption, inflammation, and fibrosis

endocrine/exocrine glands
• mice show the eventual disruption of the bile duct epithelium
• extensive bile duct hyperplasia at 6 weeks of age

growth/size/body

hematopoietic system
• IgG concentrations are increased at 6- and 24-weeks of age
• IgM concentrations are increased at 6- and 24-weeks of age

homeostasis/metabolism
• alkaline phosphatase activity in the serum is increased at 6 weeks of age
• concentration of total bile acids in the serum is increased at 6 weeks of age
• bile acid deposition in hepatocytes eventually occurs

immune system
• IgG concentrations are increased at 6- and 24-weeks of age
• IgM concentrations are increased at 6- and 24-weeks of age
• 60-90% mice exhibit increased plasma concentrations of anti-PDC-E2 mitochondrial autoantibodies
• 90% of 12-week-old mice exhibit elevated anti-gp-210 nuclear autoantibodies
• eventually mice show formation of small granulomas in the liver
• symptoms of primary biliary cholangitis are already seen at P10; intrahepatic bile duct pathology is extensive at 6 weeks, less severe in the liver parenchyma at 24 weeks, and modestly reintensified by 52 weeks
• males and females show the same features of primary biliary cholangitis
• 6 to 52-week-old mice show extensive parenchymal inflammation
• mice of all ages show increased leukocyte infiltration into the liver parenchyma; the predominant population of leukocytes is T lymphocytes in 6-week-old-mice, while 24-week-old mice show an additional accumulation of B lymphocytes, macrophages and neutrophils

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
primary biliary cholangitis DOID:12236 OMIM:PS109720
J:304105


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory